PHARMA-BIO SERV, INC.: 10-Q filed 2021-03-17

Name: PHARMA-BIO SERV, INC.: 10-Q filed 2021-03-17
Creator: PHARMA-BIO SERV, INC.

What PHARMA-BIO SERV, INC. reported in its quarterly report filed 2021-03-17 (fiscal Q1 2021): 35 published measures, 74 facts as tagged in accession 0001654954-21-002934.

This filing

Form: 10-Q (quarterly report)
Filed: 2021-03-17
Fiscal period: fiscal Q1 2021
Accession: 0001654954-21-002934 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PHARMA-BIO SERV, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2021-01-31	30,199,020	USD
At 2020-10-31	29,918,746	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2021-01-31	8,906,509	USD
At 2020-10-31	7,202,085	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2021-01-31	21,292,511	USD
At 2020-10-31	22,716,661	USD
At 2020-01-31	21,132,403	USD
At 2019-10-31	20,607,506	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2021-01-31	18,988,339	USD
At 2020-10-31	17,137,924	USD
At 2020-01-31	15,254,752	USD
At 2019-10-31	15,490,174	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2020-11-01 to 2021-01-31	268,032	USD	92
2019-11-01 to 2020-01-31	526,900	USD	92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2020-11-01 to 2021-01-31	588,186	USD	92
2019-11-01 to 2020-01-31	1,515,019	USD	92

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2020-11-01 to 2021-01-31	2,568	USD	92
2019-11-01 to 2020-01-31	11,326	USD	92

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2020-11-01 to 2021-01-31	4,488,309	USD	92
2019-11-01 to 2020-01-31	4,613,167	USD	92

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2020-11-01 to 2021-01-31	-2,851	USD	92
2019-11-01 to 2020-01-31	-1,729,696	USD	92

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2020-11-01 to 2021-01-31	1,247,432	USD	92
2019-11-01 to 2020-01-31	-11,326	USD	92

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2021-01-31	20,064,656	USD
At 2020-10-31	21,523,990	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2020-11-01 to 2021-01-31	23,010,623	shares	92
2019-11-01 to 2020-01-31	23,002,191	shares	92

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2020-11-01 to 2021-01-31	23,172,348	shares	92
2019-11-01 to 2020-01-31	23,018,537	shares	92

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2020-11-01 to 2021-01-31	53,491	USD	92
2019-11-01 to 2020-01-31	55,295	USD	92

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2021-01-31	198,716	USD
At 2020-10-31	217,572	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2020-11-01 to 2021-01-31	11,430	USD	92
2019-11-01 to 2020-01-31	11,430	USD	92

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2020-11-01 to 2021-01-31	319,121	USD	92
2019-11-01 to 2020-01-31	536,759	USD	92

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2021-01-31	28,939,422	USD
At 2020-10-31	28,584,218	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2021-01-31	5,535,133	USD
At 2020-10-31	3,792,793	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2021-01-31	9,565,325	USD
At 2020-10-31	9,727,591	USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

Period	Value	Unit	Days
2020-11-01 to 2021-01-31	0	USD	92
2019-11-01 to 2020-01-31	1,699	USD	92

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2020-11-01 to 2021-01-31	1,315,110	USD	92
2019-11-01 to 2020-01-31	1,585,892	USD	92

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

Period	Value	Unit	Days
2020-11-01 to 2021-01-31	3,173,199	USD	92
2019-11-01 to 2020-01-31	3,027,275	USD	92

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2020-11-01 to 2021-01-31	995,989	USD	92
2019-11-01 to 2020-01-31	1,049,133	USD	92

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2021-01-31	23,029,215	shares
At 2020-10-31	23,001,627	shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2021-01-31	184,406	USD
At 2020-10-31	160,654	USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

Period	Value	Unit	Days
At 2021-01-31	790,561	USD
At 2020-10-31	846,714	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2021-01-31	522,913	USD
At 2020-10-31	501,489	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2021-01-31	270,321	USD
At 2020-10-31	270,242	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2020-11-01 to 2021-01-31	321,523	USD	92
2019-11-01 to 2020-01-31	582,195	USD	92

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2020-11-01 to 2021-01-31	291,784	USD	92
2019-11-01 to 2020-01-31	515,166	USD	92

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2020-11-01 to 2021-01-31	21,424	USD	92
2019-11-01 to 2020-01-31	21,032	USD	92

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2020-11-01 to 2021-01-31	2,402	USD	92
2019-11-01 to 2020-01-31	45,436	USD	92

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2020-11-01 to 2021-01-31	852	USD	92
2019-11-01 to 2020-01-31	1,016	USD	92

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2020-11-01 to 2021-01-31	-176,864	USD	92
2019-11-01 to 2020-01-31	-1,062,141	USD	92

Inspect the source

Entity: PHARMA-BIO SERV, INC. / CIK 0001304161
Captured: 2026-09-19T11:17:27.241Z
SEC response SHA-256: bc9f33e072a9daa74aa0e8c41fbfef83d107920bc25647db80386f28787f2d49

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001304161.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))